Diabetic cardiomyopathy: Target immune cell from mechanism to treatment.

Lv J, Bao X, Jiao X, Jiang Y, Lin M, Zhang W, Wang M

DOI: 10.1016/j.intimp.2026.117116
Published: 2026 Oct 1
Container: International immunopharmacology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.117116,
  title = {Diabetic cardiomyopathy: Target immune cell from mechanism to treatment.},
  author = {Lv J and Bao X and Jiao X and Jiang Y and Lin M and Zhang W and Wang M},
  year = {2026},
  journal = {International immunopharmacology},
  doi = {10.1016/j.intimp.2026.117116},
  url = {https://doi.org/10.1016/j.intimp.2026.117116}
}

RIS

TY  - JOUR
TI  - Diabetic cardiomyopathy: Target immune cell from mechanism to treatment.
AU  - Lv J
AU  - Bao X
AU  - Jiao X
AU  - Jiang Y
AU  - Lin M
AU  - Zhang W
AU  - Wang M
PY  - 2026
JO  - International immunopharmacology
DO  - 10.1016/j.intimp.2026.117116
UR  - https://doi.org/10.1016/j.intimp.2026.117116
ER  -

APA

J, L., X, B., X, J., Y, J., M, L., W, Z., & M, W. (2026). Diabetic cardiomyopathy: Target immune cell from mechanism to treatment.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117116

Source records

pubmed · retrieved 2026-09-26T16:43:20.278Z